We are live on
!
Find out more
ACM
Accipiter Capital Management Portfolio holdings
AUM
$124M
1-Year Est. Return
6.47%
This Fund
S&P 500
This Quarter
Est. Return
+40.66%
1 Year Est. Return
-6.47%
3 Year Est. Return
-55.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$206M
AUM Growth
+$84.1M
(+69%)
Cap. Flow
+$56.4M
Cap. Flow
% of AUM
27.31%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
4
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Community Health Systems
CYH
|
+$282K |
| 2 |
Perrigo
PRGO
|
+$153K |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$67.3K |
| 4 |
QHC
Quorum Health Corporation
QHC
|
+$50.2K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$11.9M |
| 2 |
SHPG
Shire pic
SHPG
|
+$4.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.53% |
| 2 | Energy | 15.49% |
Similar funds
ACM
MCM
TCM
ALIONA
HA
DFIG
PAM
KC
Accipiter Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Accipiter Capital Management held 8 positions worth $206M, up 69% from $122M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Accipiter Capital Management deployed $56.4M of net new capital in Q3 2016, opening 1 new position and adding to 4 existing holdings.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 89% a quarter earlier, followed by Energy.
On the sell side, the largest reduction was Bausch Health, an estimated $11.9M trimmed.
- Accipiter Capital Management added most to Community Health Systems in Q3 2016, an estimated $282K increase.
- Accipiter Capital Management's biggest Q3 2016 reduction was Bausch Health, cutting an estimated $11.9M.
- Accipiter Capital Management's ten largest holdings make up 100% of its $206M portfolio in Q3 2016.
- Accipiter Capital Management opened 1 new position and closed 0 in Q3 2016.
- Accipiter Capital Management's portfolio value rose 69% quarter-over-quarter to $206M.
Based on Accipiter Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.